Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage fr

StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James started coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 price target for the […]

Related Keywords

Dawson James , Zembrace Symtouch , Tonix Pharmaceuticals Holding Corp , Sabby Management , Geode Capital Management , Institutional Investors Weigh In On Tonix Pharmaceuticals , Tonix Pharmaceuticals Stock Down , Tonix Pharmaceuticals , Jpmorgan Chase Co , Tonix Pharmaceuticals Company Profile , News Ratings For Tonix Pharmaceuticals Daily , Armistice Capital , Free Report , Pharmaceuticals Stock Down , Street Corp , Capital Management , Get Free Report , Pharmaceuticals Holding Corp , Tonix Pharmaceuticals Daily , Nasdaq Tnxp , Tnxp , Medical , Initiated Coverage , Stocknews Com ,